]>
IRCT20221024056281N3 IRCT 2026-10-14 University of Tehran Effectiveness of the Coping Long-Term with Active Suicide Program in Suicide Attempters Effectiveness of the Coping Long-Term with Active Suicide Program (CLASP) in Reducing Suicide Motivational Factors in Suicide Attempters 2025-11-20 anticipated 77 Complete https://irct.ir/trial/91609 interventional Randomization: Not randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Prevention. N/A Individuals with a history of suicide attempts. Intervention 1: First intervention group: Coping Long-Term with Active Suicide Program: Participants in this group received the Coping Long-Term with Active Suicide Program (CLASP) over a six-month period. This intervention is a follow-up and adjunctive psychological program to usual treatments, designed to reduce the risk of recurrent suicidal behavior and to target psychological and behavioral factors associated with the continuation of risk. The program consisted of three individual face-to-face sessions, one family session, and 11 post-discharge follow-up telephone contacts.During the three individual face-to-face sessions, the intervention content included assessment of factors associated with the suicide attempt and level of risk, review of experiences and factors contributing to the crisis, development and review of a safety plan, identification of risk-enhancing and protective factors, training in coping skills, enhancement of problem-solving skills, reduction of hopelessness, strengthening motivation for continued living, identification of individual values and goals, and enhancement of adherence to treatment and follow-up with mental health services.The family session was conducted with the participant and one key family member or support person and focused on increasing social support, improving family communication, identifying warning signs, training on how to support the individual during crisis situations, and involving the family in the prevention of suicidal behavior.After the face-to-face sessions, 11 follow-up telephone contacts were conducted over six months. Each contact lasted approximately 15 to 30 minutes and included monitoring psychological status, reassessment of suicide risk, review of problems and stressors, review of coping skills and the safety plan, review of receipt of treatment services, strengthening supportive contact, and providing support during crisis situations. Intervention 2: Second intervention group: Coping Long-Term with Active Suicide Program (CLASP) plus pharmacotherapy: Participants in this group, in addition to receiving the Coping Long-Term with Active Suicide Program (CLASP), also received usual pharmacological treatment under the supervision of the treating psychiatrist. The Coping Long-Term with Active Suicide Program was implemented over a six-month period and consisted of three individual face-to-face sessions, one family session, and 11 follow-up telephone contacts.The individual sessions focused on assessment of factors associated with suicidal behavior and level of risk, development and review of a safety plan, identification of triggers and warning signs, training and strengthening of coping skills, enhancement of problem-solving skills, reduction of hopelessness, strengthening motivation for continued living, and increasing adherence to treatment.The family session was conducted with the aim of increasing the participation of a significant person in the participant’s life or a family member in the treatment process, enhancing social support, providing training in the identification of warning signs, improving family communication, and establishing an effective support network for the prevention of suicidal behavior.The follow-up telephone contacts were conducted over six months after discharge, with each contact lasting approximately 15 to 30 minutes. These contacts were intended to monitor psychological status, reassess suicide risk, review the safety plan, assess barriers to treatment, strengthen coping strategies, and provide support during crisis situations.Pharmacotherapy was provided based on the psychiatrist’s clinical assessment, the diagnosis of comorbid disorders, the individual’s clinical condition, and the treatment protocol of the center. The type of medication, dosage, and changes in pharmacological treatment were determined according to the treating psychiatrist’s judgment and the condition of each patient, and participants in this group received standard pharmacological care alongside the psychological intervention. Intervention 3: Third intervention group: Pharmacotherapy alone: Participants in this group received usual pharmacotherapy under the supervision of a psychiatrist, based on the clinical diagnosis, the patient's condition, and the treatment program of the center. Pharmacotherapy continued throughout the six-month study period, and the type and dose of medication were adjusted according to each patient's clinical condition by the treating psychiatrist. Intervention 4: Control group: control: Participants in this group did not receive any active intervention during the study period. They were provided with access to treatment services after completion of the follow-up period. No - There is not a plan to make this available Justification or reason for not sharing IPD is Due to the sensitive nature of individual participant data, particularly information related to suicide attempts and psychological variables, identifiable individual-level data will not be publicly shared. Data sharing may compromise participants’ confidentiality and privacy. Upon a valid scientific request and ethical review, limited access to anonymized data may be considered.
public Hedieh Babakhanzadeh
Kardan St., Jalal Al-e Ahmad Hwy., Faculty of Psychology and Education, University of Tehran, Tehran, Iran
Tehran Iran (Islamic Republic of) 1445983861 +98 21 8823 4409 Hedieh.khanzadeh@yahoo.com University of Tehran scientific Hedieh Babakhanzadeh
Kardan St., Jalal Al-e Ahmad Hwy., Faculty of Psychology and Education, University of Tehran, Tehran, Iran
Tehran Iran (Islamic Republic of) 1445983861 +98 21 8823 4409 Hedieh.khanzadeh@yahoo.com Tehran University Iran (Islamic Republic of) Age 18–60 years Having at least one suicide attempt within the past six months Providing informed consent to participate in the study no questionnaire score or cutoff was defined as an eligibility criterion. The Beck Scale for Suicide Ideation and the Inventory of Motivations for Suicide Attempts were used to measure the study variables. 18 years 60 years Both Diagnosis of active psychotic disorder Severe cognitive impairment T14.91 Suicide attempt Prevention Prevention Prevention N/A First intervention group: Coping Long-Term with Active Suicide Program: Participants in this group received the Coping Long-Term with Active Suicide Program (CLASP) over a six-month period. This intervention is a follow-up and adjunctive psychological program to usual treatments, designed to reduce the risk of recurrent suicidal behavior and to target psychological and behavioral factors associated with the continuation of risk. The program consisted of three individual face-to-face sessions, one family session, and 11 post-discharge follow-up telephone contacts.During the three individual face-to-face sessions, the intervention content included assessment of factors associated with the suicide attempt and level of risk, review of experiences and factors contributing to the crisis, development and review of a safety plan, identification of risk-enhancing and protective factors, training in coping skills, enhancement of problem-solving skills, reduction of hopelessness, strengthening motivation for continued living, identification of individual values and goals, and enhancement of adherence to treatment and follow-up with mental health services.The family session was conducted with the participant and one key family member or support person and focused on increasing social support, improving family communication, identifying warning signs, training on how to support the individual during crisis situations, and involving the family in the prevention of suicidal behavior.After the face-to-face sessions, 11 follow-up telephone contacts were conducted over six months. Each contact lasted approximately 15 to 30 minutes and included monitoring psychological status, reassessment of suicide risk, review of problems and stressors, review of coping skills and the safety plan, review of receipt of treatment services, strengthening supportive contact, and providing support during crisis situations. Second intervention group: Coping Long-Term with Active Suicide Program (CLASP) plus pharmacotherapy: Participants in this group, in addition to receiving the Coping Long-Term with Active Suicide Program (CLASP), also received usual pharmacological treatment under the supervision of the treating psychiatrist. The Coping Long-Term with Active Suicide Program was implemented over a six-month period and consisted of three individual face-to-face sessions, one family session, and 11 follow-up telephone contacts.The individual sessions focused on assessment of factors associated with suicidal behavior and level of risk, development and review of a safety plan, identification of triggers and warning signs, training and strengthening of coping skills, enhancement of problem-solving skills, reduction of hopelessness, strengthening motivation for continued living, and increasing adherence to treatment.The family session was conducted with the aim of increasing the participation of a significant person in the participant’s life or a family member in the treatment process, enhancing social support, providing training in the identification of warning signs, improving family communication, and establishing an effective support network for the prevention of suicidal behavior.The follow-up telephone contacts were conducted over six months after discharge, with each contact lasting approximately 15 to 30 minutes. These contacts were intended to monitor psychological status, reassess suicide risk, review the safety plan, assess barriers to treatment, strengthen coping strategies, and provide support during crisis situations.Pharmacotherapy was provided based on the psychiatrist’s clinical assessment, the diagnosis of comorbid disorders, the individual’s clinical condition, and the treatment protocol of the center. The type of medication, dosage, and changes in pharmacological treatment were determined according to the treating psychiatrist’s judgment and the condition of each patient, and participants in this group received standard pharmacological care alongside the psychological intervention. Third intervention group: Pharmacotherapy alone: Participants in this group received usual pharmacotherapy under the supervision of a psychiatrist, based on the clinical diagnosis, the patient's condition, and the treatment program of the center. Pharmacotherapy continued throughout the six-month study period, and the type and dose of medication were adjusted according to each patient's clinical condition by the treating psychiatrist. Control group: control: Participants in this group did not receive any active intervention during the study period. They were provided with access to treatment services after completion of the follow-up period. Suicidal ideation score based on the Beck Scale for Suicide Ideation(BSSI). Timepoint: Suicidality was measured at baseline (before the intervention), and at three- and six-month follow-ups after the intervention. Method of measurement: Beck Scale for Suicide Ideation (BSSI). Suicidal motivation score based on the Inventory of Motivations for Suicide Attempts(IMSA). Timepoint: Suicide motivation was measured at baseline (before the intervention), and at three- and six-month follow-ups after the intervention. Method of measurement: Inventory of Motivations for Suicide Attempts (IMSA). University of Tehran Approved 2025-11-17 Ethics Committee, Faculty of Psychology and Education, University of Tehran Kardan St., Jalal Al-e Ahmad Highway, Tehran Tehran Tehran Iran (Islamic Republic of)